Welcome to Yeast Infection Solution
.... a sure-fire, 100% guaranteed, clinically researched system that is backed by 25,000+ hours of nutritional expertise for eliminating yeast infection for good. This is a very rare, highly unique and potently powerful candida healing system, which very few people even know exists.......more
Updates on Candidiasis Yeast Infection
MethylGene Reports First Quarter 2012 Financial Results and Provides an Update on Clinical Programs
MONTREAL, QUEBEC-- - MethylGene Inc. today reported financial results for the first quarter ended March 31, 2012 and provided an update on clinical programs. Highlights-- Rachel W. Humphrey, MD was appointed as Executive Vice President and Chief Medical Officer on January 4, 2012. -- During this quarter, we strengthened our Board of Directors with the appointments of Henry J. Fuchs MD ...
Read more...‘Cross-kingdom’ vaccine may protect against fungal and bacterial infections
A clinical-stage pharmaceutical company with a vaccine it says uses a single antigen to protect against both fungal and bacterial infections is looking for a series B round to fund phase 2 trials for hospital-associated infection and women’s health applications next year. NovaDigm Therapeutics’ lead product, the NDV-3 vaccine, targets the fungal infection candida and the [...]
Read more...New Research extends the Benefit of BLIS K12
A recent study by Canadian and Japanese researchers shows new benefits for the BLIS K12 probiotic. BLIS Technologies Ltd (NZX: BLT) has reported that this new research, published in the international journal Applied and Environmental Microbiology, further ...
Read more...NovaDigm Therapeutics Presents Positive Safety and Immunogenicity Data in a Second Phase 1 Study for NDV-3 Vaccine
NovaDigm Therapeutics, a company developing innovative vaccines for fungal and bacterial infections, today announced the presentation of positive data for its NDV-3 vaccine program in a second Phase 1 study.
Read more...
